exp7711 has been researched along with up 269-6 in 1 studies
| Studies (exp7711) | Trials (exp7711) | Recent Studies (post-2010) (exp7711) | Studies (up 269-6) | Trials (up 269-6) | Recent Studies (post-2010) (up 269-6) |
|---|---|---|---|---|---|
| 18 | 0 | 1 | 15 | 4 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR | 1 |
1 review(s) available for exp7711 and up 269-6
| Article | Year |
|---|---|
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship | 1996 |